Familial and attributable risks in cutaneous melanoma: effects of proband and age.

We studied familial risks in invasive and in situ cutaneous melanoma by comparing the occurrence of melanoma, or discordant cancer, between parents and offspring, and between siblings, based on the Swedish Family Cancer Database of over 10 million individuals. Offspring were 0-66 y of age. Cancers were obtained from the Swedish Cancer Registry from 1961 to 1998. The study was based on 24,818 invasive and 5510 in situ cases of melanoma. Standardized incidence ratios were calculated for familial risk. The standardized incidence ratios for offspring was 2.40 (95% confidence intervals: 2.10-2.72) when only the parent had melanoma and it was 2.98 (95% confidence intervals: 2.54-3.47) when only a sibling was affected; when both a parent and a sibling were affected the standardized incidence ratios was 8.92 (95% confidence intervals: 4.25-15.31). The respective population attributable risks were 1.38, 1.20, and 0.10%. The familial risk showed a clear age dependence and somewhat higher risk in in situ melanoma than in the invasive counterpart. The highest standardized incidence ratio of 61.78 (5.82-227.19) was noted for offspring whose parent had multiple melanomas. Superficially spreading melanoma showed the highest familial risk both among invasive and in situ tumors. Melanoma associated with breast, nervous system, and skin cancers, and in situ melanoma possibly also with connective tissue and thyroid tumors and multiple myeloma.

[1]  H. Møller,et al.  Second primary cancers in patients with squamous cell carcinoma of the skin , 2004, British Journal of Cancer.

[2]  K. Czene,et al.  Attributable risks of familial cancer from the Family-Cancer Database. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  K. Hemminki,et al.  Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. , 2002, The American journal of pathology.

[4]  Florence Demenais,et al.  Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.

[5]  K. Hemminki,et al.  Cancer risks among long-standing spouses , 2002, British Journal of Cancer.

[6]  K. Czene,et al.  Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.

[7]  K. Hemminki,et al.  In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients , 2002, International journal of cancer.

[8]  Maria Teresa Landi,et al.  DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. , 2002, Journal of the National Cancer Institute.

[9]  U. Ringborg,et al.  Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994 , 2002, Acta oncologica.

[10]  K. Hemminki,et al.  A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare , 2001, International journal of cancer.

[11]  J. Bolognia,et al.  The melanocortin-1 receptor: red hair and beyond. , 2001, Archives of dermatology.

[12]  L. Sandkuijl,et al.  Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. , 2001, American journal of human genetics.

[13]  K. Hemminki,et al.  Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. , 2001 .

[14]  J. Peto,et al.  Genetics and the common cancers. , 2001, European journal of cancer.

[15]  M T Landi,et al.  Combined risk factors for melanoma in a Mediterranean population , 2001, British Journal of Cancer.

[16]  R. Willemze,et al.  Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.

[17]  J. Barrett,et al.  Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.

[18]  N. Risch,et al.  The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  V. P. Collins,et al.  Parental Cancer as a Risk Factor for Brain Tumors (Sweden) , 2001, Cancer Causes & Control.

[20]  K. Hemminki,et al.  A population-based study of familial soft tissue tumors. , 2001, Journal of clinical epidemiology.

[21]  K. Hemminki,et al.  Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families , 2001, International journal of cancer.

[22]  K. Hemminki,et al.  A population-based study of familial cutaneous melanoma , 2001, Melanoma research.

[23]  K. Hemminki,et al.  Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. , 2001, Journal of the National Cancer Institute.

[24]  D. Easton,et al.  Sibling risks in cancer: clues to recessive or X-linked genes? , 2001, British Journal of Cancer.

[25]  K. Hemminki,et al.  Cancer risks to spouses and offspring in the family‐cancer database , 2001, Genetic epidemiology.

[26]  P Vineis,et al.  Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. , 2000, Journal of the National Cancer Institute.

[27]  Å. Borg,et al.  High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma Families , 2000 .

[28]  J. Rees,et al.  The melanocortin 1 receptor (MC1R): more than just red hair. , 2000, Pigment cell research.

[29]  K. Hemminki,et al.  Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. , 2000, Archives of dermatology.

[30]  K. Hemminki,et al.  Cutaneous melanoma patients have normal repair kinetics of ultraviolet-induced DNA repair in skin in situ. , 2000, The Journal of investigative dermatology.

[31]  P. Brennan,et al.  Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia , 2000, British Journal of Cancer.

[32]  U. Ringborg,et al.  Cancer risk in patients with earlier diagnosis of cutaneous melanoma In situ , 1999, International journal of cancer.

[33]  M. Greene The genetics of hereditary melanoma and nevi , 1999, Cancer.

[34]  J F Aitken,et al.  A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.

[35]  D. Duffy,et al.  CDKN2A variants in a population-based sample of Queensland families with melanoma. , 1999, Journal of the National Cancer Institute.

[36]  A. Burden,et al.  Genetic and environmental influences in the development of multiple primary melanoma. , 1999, Archives of dermatology.

[37]  U. Ringborg,et al.  Second primary cancers in patients with squamous cell carcinoma of the skin: A population‐based study in Sweden , 1999, International journal of cancer.

[38]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[39]  P. Kyyrönen,et al.  Age‐specific familial risks in common cancers of the offspring , 1998, International journal of cancer.

[40]  L. Fritschi,et al.  Characteristics of familial and non-familial melanoma in Australia , 1998, Melanoma research.

[41]  K. Hemminki,et al.  Familial risks in in situ cancers from the Family-Cancer Database. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  R. Severson,et al.  The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma , 1998, Cancer.

[43]  C. la Vecchia,et al.  Incidence of invasive cancers following basal cell skin cancer. , 1998, American journal of epidemiology.

[44]  E. Fearon Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.

[45]  D. Bishop,et al.  Germline mutations of the CDKN2 gene in UK melanoma families. , 1997, Human molecular genetics.

[46]  C. la Vecchia,et al.  Incidence of invasive cancers following squamous cell skin cancer. , 1997, American journal of epidemiology.

[47]  M. Inganäs,et al.  Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. , 1997, Journal of the National Cancer Institute.

[48]  Bruce K. Armstrong,et al.  Sunlight and cancer , 1997, Cancer Causes & Control.

[49]  C. la Vecchia,et al.  Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. , 1996, British Journal of Cancer.

[50]  R. MacKie,et al.  Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. , 1996, British Journal of Cancer.

[51]  U. Ringborg,et al.  Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. , 1996, British Journal of Cancer.

[52]  M. Tucker,et al.  Genetic epidemiology of familial melanoma. , 1995, Dermatologic clinics.

[53]  M. Melbye,et al.  Evidence of an association between non-Hodgkin's lymphoma and skin cancer , 1995, BMJ.

[54]  A. Swerdlow,et al.  Risks of second primary malignancy in patients with cutaneous and ocular melanoma in denmark, 1943–1989 , 1995, International journal of cancer.

[55]  M. Melbye,et al.  New primary cancers after squamous cell skin cancer. , 1995, American journal of epidemiology.

[56]  M H Skolnick,et al.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.

[57]  S. Wacholder,et al.  Second cancers among long-term survivors of non-Hodgkin's lymphoma. , 1993, Journal of the National Cancer Institute.

[58]  B. Hankey,et al.  Second cancers following non‐Hodgkin's lymphoma , 1991, Cancer.

[59]  O S Miettinen,et al.  Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.

[60]  N. Risch,et al.  Genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches Cancer Epidemiol. Biomark , 2002 .

[61]  K. Hemminki,et al.  Primary cancers following squamous cell carcinoma of the skin suggest involvement of Epstein-Barr virus. , 2000, Epidemiology.

[62]  U. Ringborg,et al.  Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study. , 1999, Acta oncologica.

[63]  H. Olsson Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.

[64]  K. Hemminki,et al.  National database of familial cancer in Sweden , 1998, Genetic epidemiology.

[65]  J. Aitken,et al.  Segregation analysis of cutaneous melanoma in Queensland , 1998, Genetic epidemiology.

[66]  J. Elwood,et al.  Melanoma and ultraviolet radiation. , 1992, Clinics in dermatology.

[67]  B. Macmahon,et al.  Epidemiology: Principles and Methods , 1970 .